133 related articles for article (PubMed ID: 1381005)
1. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease.
Scandling JD; Myers BD
Kidney Int; 1992 Apr; 41(4):840-6. PubMed ID: 1381005
[TBL] [Abstract][Full Text] [Related]
2. Glomerular permselectivity in early stages of overt diabetic nephropathy.
Andersen S; Blouch K; Bialek J; Deckert M; Parving HH; Myers BD
Kidney Int; 2000 Nov; 58(5):2129-37. PubMed ID: 11044234
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier.
Friedman S; Jones HW; Golbetz HV; Lee JA; Little HL; Myers BD
Diabetes; 1983 May; 32 Suppl 2():40-6. PubMed ID: 6086024
[TBL] [Abstract][Full Text] [Related]
4. Functional nature of glomerular injury in progressive diabetic glomerulopathy.
Tomlanovich S; Deen WM; Jones HW; Schwartz HC; Myers BD
Diabetes; 1987 May; 36(5):556-65. PubMed ID: 2436961
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of proteinuria in diabetic glomerular disease.
Myers BD
J Hypertens Suppl; 1990 Mar; 8(1):S41-6. PubMed ID: 2332816
[TBL] [Abstract][Full Text] [Related]
6. Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus.
Lemley KV; Blouch K; Abdullah I; Boothroyd DB; Bennett PH; Myers BD; Nelson RG
J Am Soc Nephrol; 2000 Nov; 11(11):2095-2105. PubMed ID: 11053486
[TBL] [Abstract][Full Text] [Related]
7. Effects of exercise on glomerular passage of macromolecules in patients with diabetic nephropathy and in healthy subjects.
Ala-Houhala I
Scand J Clin Lab Invest; 1990 Feb; 50(1):27-33. PubMed ID: 1690442
[TBL] [Abstract][Full Text] [Related]
8. Reduction in mean glomerular pore size coincides with the development of large shunt pores in patients with diabetic nephropathy.
Oberbauer R; Nenov V; Weidekamm C; Haas M; Szekeres T; Mayer G
Exp Nephrol; 2001; 9(1):49-53. PubMed ID: 11053980
[TBL] [Abstract][Full Text] [Related]
9. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
Carrie BJ; Myers BD
Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
[TBL] [Abstract][Full Text] [Related]
10. Charge selectivity of proteinuria in diabetic glomerulopathy.
Nakamura Y; Myers BD
Diabetes; 1988 Sep; 37(9):1202-11. PubMed ID: 3410164
[TBL] [Abstract][Full Text] [Related]
11. Fractional dextran and protein clearances in glomerulonephritis and in diabetic nephropathy.
Ala-Houhala I; Pasternack A
Clin Sci (Lond); 1987 Mar; 72(3):289-96. PubMed ID: 2434282
[TBL] [Abstract][Full Text] [Related]
12. Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy.
Adler SG; Kang SW; Feld S; Cha DR; Barba L; Striker L; Striker G; Riser BL; LaPage J; Nast CC
Kidney Int; 2001 Dec; 60(6):2330-6. PubMed ID: 11737607
[TBL] [Abstract][Full Text] [Related]
13. Glomerular charge selectivity in type 1 (insulin-dependent) diabetes mellitus.
Fox JG; Quin JD; Paterson KR; O'Reilly DS; Smith MP; Boulton-Jones JM
Diabet Med; 1995 May; 12(5):387-91. PubMed ID: 7648799
[TBL] [Abstract][Full Text] [Related]
14. Progression of overt nephropathy in non-insulin-dependent diabetes.
Myers BD; Nelson RG; Tan M; Beck GJ; Bennett PH; Knowler WC; Blouch K; Mitch WE
Kidney Int; 1995 Jun; 47(6):1781-9. PubMed ID: 7543961
[TBL] [Abstract][Full Text] [Related]
15. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.
Zietse R; Derkx FH; Weimar W; Schalekamp MA
J Am Soc Nephrol; 1995 Jun; 5(12):2057-66. PubMed ID: 7579054
[TBL] [Abstract][Full Text] [Related]
16. Determinants of the penetration of proteins through the glomerular barrier in insulin-dependent diabetes mellitus.
Viberti G; Mackintosh D; Keen H
Diabetes; 1983 May; 32 Suppl 2():92-5. PubMed ID: 6600038
[TBL] [Abstract][Full Text] [Related]
17. Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset.
Myers BD; Nelson RG; Williams GW; Bennett PH; Hardy SA; Berg RL; Loon N; Knowler WC; Mitch WE
J Clin Invest; 1991 Aug; 88(2):524-30. PubMed ID: 1864963
[TBL] [Abstract][Full Text] [Related]
18. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
Morelli E; Loon N; Meyer T; Peters W; Myers BD
Diabetes; 1990 Jan; 39(1):76-82. PubMed ID: 1698674
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function.
Myers BD; Winetz JA; Chui F; Michaels AS
Kidney Int; 1982 Apr; 21(4):633-41. PubMed ID: 6178872
[TBL] [Abstract][Full Text] [Related]
20. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
Ruggenenti P; Mosconi L; Sangalli F; Casiraghi F; Gambara V; Remuzzi G; Remuzzi A
Kidney Int; 1999 Mar; 55(3):984-94. PubMed ID: 10027935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
